These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Resolution of inflammation: Intervention strategies and future applications. Panezai J; Van Dyke TE Toxicol Appl Pharmacol; 2022 Aug; 449():116089. PubMed ID: 35644268 [TBL] [Abstract][Full Text] [Related]
9. The role of specialized pro-resolving mediators (SPMs) in inflammatory arthritis: A therapeutic strategy. Natami M; Hosseini SM; Khaleel RA; Addulrahman TS; Zarei M; Asadi S; Gholami S; Mehrvar A Prostaglandins Other Lipid Mediat; 2024 Feb; 170():106798. PubMed ID: 37977352 [TBL] [Abstract][Full Text] [Related]
10. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711 [TBL] [Abstract][Full Text] [Related]
11. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553 [TBL] [Abstract][Full Text] [Related]
12. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Kim AS; Conte MS Adv Drug Deliv Rev; 2020; 159():170-179. PubMed ID: 32697951 [TBL] [Abstract][Full Text] [Related]
13. The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification. Carracedo M; Artiach G; Arnardottir H; Bäck M Semin Immunopathol; 2019 Nov; 41(6):757-766. PubMed ID: 31696250 [TBL] [Abstract][Full Text] [Related]
17. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease. Schaller MS; Chen M; Colas RA; Sorrentino TA; Lazar AA; Grenon SM; Dalli J; Conte MS J Am Heart Assoc; 2020 Aug; 9(15):e016113. PubMed ID: 32696697 [TBL] [Abstract][Full Text] [Related]
18. Quenching the fires: Pro-resolving mediators, air pollution, and smoking. Thatcher TH; Woeller CF; McCarthy CE; Sime PJ Pharmacol Ther; 2019 May; 197():212-224. PubMed ID: 30759375 [TBL] [Abstract][Full Text] [Related]
19. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis. Lubrano V; Ndreu R; Balzan S Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675152 [TBL] [Abstract][Full Text] [Related]
20. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation. Radbakhsh S; Katsiki N; Santos RD; Mikhailidis DP; Mantzoros CS; Sahebkar A Metabolism; 2022 Jul; 132():155211. PubMed ID: 35533891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]